Colonisation with Extended-Spectrum Cephalosporin-Resistant Enterobacterales and Infection Risk in Surgical Patients: A Systematic Review and Meta-analysis.
Extended-spectrum cephalosporin-resistant Enterobacterales (ESCR-E)
Meta-analysis
Postoperative infections
Rectal colonisation
Surgical site infections
Journal
Infectious diseases and therapy
ISSN: 2193-8229
Titre abrégé: Infect Dis Ther
Pays: New Zealand
ID NLM: 101634499
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
14
09
2022
accepted:
21
12
2022
pubmed:
13
1
2023
medline:
13
1
2023
entrez:
12
1
2023
Statut:
ppublish
Résumé
Limited evidence has been reported for surgical site infections (SSIs) in patients undergoing surgery who are carriers of extended-spectrum cephalosporin-resistant Enterobacterales (ESCR-E). A systematic review and meta-analysis were conducted to evaluate the risk of postoperative infections in adult inpatients colonised with ESCR-E before surgery. The Medline, Embase and Cochrane databases were searched between January 2011 and April 2022, following PRISMA indications. Random effects meta-analysis was used to quantify the association between ESCR-E colonisation and infection. Among the 467 articles reviewed, 9 observational studies encompassing 7219 adult patients undergoing surgery were included. The ESCR-E colonisation rate was 13.7% (95% CI 7.7-19.7). The most commonly reported surgeries included abdominal surgery (44%) and liver transplantation (LT; 33%). The SSI rate was 23.2% (95% CI 13.2-33.1). Pooled incidence risk was 0.36 (95% CI 0.22-0.50) vs 0.13 (95% CI 0.02-0.24) for any postoperative infection and 0.28 (95% CI 0.18-0.38) vs 0.17 (95% CI 0.07-0.26) for SSIs in ESCR-E carriers vs noncarriers, respectively. In ESCR-E carriers, the ESCR-E infection ratio was 7 times higher than noncarriers. Postoperative infection risk was higher in carriers versus noncarriers following LT. Sources of detected heterogeneity between studies included ESCR-E colonisation and the geographic region of origin. Patients colonised with ESCR-E before surgery had increased incidence rates of post-surgical infections and SSIs compared to noncarriers. Our results suggest considering the implementation of pre-surgical screening for detecting ESCR-E colonisation status according to the type of surgery and the local epidemiology.
Identifiants
pubmed: 36633819
doi: 10.1007/s40121-022-00756-z
pii: 10.1007/s40121-022-00756-z
pmc: PMC9925622
doi:
Types de publication
Journal Article
Langues
eng
Pagination
623-636Informations de copyright
© 2023. The Author(s).
Références
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–27.
doi: 10.1016/S1473-3099(17)30753-3
pubmed: 29276051
Williams DN. Antimicrobial resistance: are we at the dawn of the post-antibiotic era? J R Coll Physicians Edinb. 2016;46(3):150–6.
doi: 10.4997/jrcpe.2016.302
pubmed: 27959347
Bajaj P, Singh NS, Virdi JS. Escherichia coli beta-lactamases: what really matters. Front Microbiol. 2016;7:417.
doi: 10.3389/fmicb.2016.00417
pubmed: 27065978
pmcid: 4811930
Rodriguez-Bano J, Pascual A. Clinical significance of extended-spectrum beta-lactamases. Expert Rev Anti Infect Ther. 2008;6(5):671–83.
doi: 10.1586/14787210.6.5.671
pubmed: 18847405
Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017;96(1):1–15.
doi: 10.1016/j.jhin.2017.03.004
pubmed: 28410761
Bert F, Larroque B, Dondero F, Durand F, Paugam-Burtz C, Belghiti J, et al. Risk factors associated with preoperative fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transpl Infect Dis. 2014;16(1):84–9.
doi: 10.1111/tid.12169
pubmed: 24330161
Linares L, Cervera C, Cofan F, Ricart MJ, Esforzado N, Torregrosa V, et al. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc. 2007;39(7):2222–4.
doi: 10.1016/j.transproceed.2007.06.061
pubmed: 17889144
Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29(12):1099–106.
doi: 10.1086/592412
pubmed: 18973455
Golzarri MF, Silva-Sanchez J, Cornejo-Juarez P, Barrios-Camacho H, Chora-Hernandez LD, Velazquez-Acosta C, et al. Colonization by fecal extended-spectrum beta-lactamase-producing Enterobacteriaceae and surgical site infections in patients with cancer undergoing gastrointestinal and gynecologic surgery. Am J Infect Control. 2019;47(8):916–21.
doi: 10.1016/j.ajic.2019.01.020
pubmed: 30850249
Apisarnthanarak A, Kondo S, Mingmalairak C, Mahawongkajit P, Juntong J, Limpavitayaporn P, et al. Outcomes of extended-spectrum beta-lactamases producing Enterobacteriaceae colonization among patients abdominal surgery patients. Infect Control Hosp Epidemiol. 2019;40(11):1290–3.
doi: 10.1017/ice.2019.254
pubmed: 31481134
Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013;14(1):73–156.
doi: 10.1089/sur.2013.9999
pubmed: 23461695
Allegranzi B, Zayed B, Bischoff P, Kubilay NZ, de Jonge S, de Vries F, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16(12):e288–303.
doi: 10.1016/S1473-3099(16)30402-9
pubmed: 27816414
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.
Wells B, Saskin R, Wright F, McCready D, Quan ML. Measuring the quality of sentinel lymph node biopsy (SLNB) for breast cancer: a population-based evaluation. Ann Surg Oncol. 2013;20(2):615–9.
doi: 10.1245/s10434-012-2626-6
pubmed: 22941174
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
doi: 10.1016/0197-2456(86)90046-2
pubmed: 3802833
Metelli S, Chaimani A. Challenges in meta-analyses with observational studies. Evid Based Ment Health. 2020;23(2):83–7.
doi: 10.1136/ebmental-2019-300129
pubmed: 32139442
Egger M, Schneider M, Davey SG. Spurious precision? Meta-analysis of observational studies. BMJ. 1998;316(7125):140–4.
doi: 10.1136/bmj.316.7125.140
pubmed: 9462324
pmcid: 2665367
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
doi: 10.1002/sim.1186
pubmed: 12111919
Bert F, Larroque B, Paugam-Burtz C, Dondero F, Durand F, Marcon E, et al. Pretransplant fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and infection after liver transplant, France. Emerg Infect Dis. 2012;18(6):908–16.
doi: 10.3201/eid1806.110139
pubmed: 22607885
pmcid: 3358139
De Pastena M, Paiella S, Azzini AM, Zaffagnini A, Scarlini L, Montagnini G, et al. Antibiotic prophylaxis with piperacillin-tazobactam reduces post-operative infectious complication after pancreatic surgery: an interventional, non-randomized study. Surg Infect (Larchmt). 2021;22(5):536–42.
doi: 10.1089/sur.2020.260
pubmed: 33095107
Dubinsky-Pertzov B, Temkin E, Harbarth S, Fankhauser-Rodriguez C, Carevic B, Radovanovic I, et al. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and the risk of surgical site infection after colorectal surgery: a prospective cohort study. Clin Infect Dis. 2019;68(10):1699–704.
doi: 10.1093/cid/ciy768
pubmed: 30204851
Freire MP, Villela Soares Oshiro IC, Bonazzi PR, Pierrotti LC, de Oliveira LM, Machado AS, et al. Surveillance culture for multidrug-resistant gram-negative bacteria: performance in liver transplant recipients. Am J Infect Control. 2017;45(3):e40–e44.
Bloomfield MG, Page MJ, McLachlan AG, Studd RC, Blackmore TK. Routine ertapenem prophylaxis for transrectal ultrasound guided prostate biopsy does not select for carbapenem resistant organisms: a prospective cohort study. J Urol. 2017;198(2):362–8.
doi: 10.1016/j.juro.2017.03.077
pubmed: 28288838
Macesic N, Gomez-Simmonds A, Sullivan SB, Giddins MJ, Ferguson SA, Korakavi G, et al. Genomic surveillance reveals diversity of multidrug-resistant organism colonization and infection: a prospective cohort study in liver transplant recipients. Clin Infect Dis. 2018;67(6):905–12.
doi: 10.1093/cid/ciy199
pubmed: 29718144
pmcid: 6117442
Logre E, Bert F, Khoy-Ear L, Janny S, Giabicani M, Grigoresco B, et al. Risk factors and impact of perioperative prophylaxis on the risk of extended-spectrum beta-lactamase-producing enterobacteriaceae-related infection among carriers following liver transplantation. Transplantation. 2021;105(2):338–45.
doi: 10.1097/TP.0000000000003231
pubmed: 32217945
Sewell J, Chow K, De Sousa A, Sapre N, Norris B, Namdarian B, et al. Extended-spectrum beta-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital. BJU Int. 2019;123(Suppl 5):43–6.
doi: 10.1111/bju.14745
pubmed: 31012990
Gandra S, Trett A, Alvarez-Uria G, Solomkin JS, Laxminarayan R. Is the efficacy of antibiotic prophylaxis for surgical procedures decreasing? Systematic review and meta-analysis of randomized control trials. Infect Control Hosp Epidemiol. 2019;40(2):133–41.
doi: 10.1017/ice.2018.295
pubmed: 30417800
Pfeffer I, Zemel M, Kariv Y, Mishali H, Adler A, Braun T, et al. Prevalence and risk factors for carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients prior to bowel surgery. Diagn Microbiol Infect Dis. 2016;85(3):377–80.
doi: 10.1016/j.diagmicrobio.2016.04.002
pubmed: 27133560
Alevizakos M, Karanika S, Detsis M, Mylonakis E. Colonisation with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016;48(6):647–54.
doi: 10.1016/j.ijantimicag.2016.08.021
pubmed: 27746102
Grasselli G, Scaravilli V, Alagna L, et al. Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome. Ann Intensive Care. 2019;9(1):141.
doi: 10.1186/s13613-019-0615-7
pubmed: 31853672
pmcid: 6920277
Aguado JM, Silva JT, Fernandez-Ruiz M, Cordero E, Fortun J, Gudiol C, et al. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplant Rev (Orlando). 2018;32(1):36–57.
doi: 10.1016/j.trre.2017.07.001
pubmed: 28811074
Nutman A, Temkin E, Harbarth S, Carevic B, Ris F, Fankhauser-Rodriguez C, et al. Personalized ertapenem prophylaxis for carriers of extended-spectrum beta-lactamase-producing Enterobacteriaceae undergoing colorectal surgery. Clin Infect Dis. 2020;70(9):1891–7.